Yaz Lawsuit Updates

FDA to Consider new Yaz/Yasmin Warnings Next Month

December 8 Meeting Scheduled to Discuss 6 Studies Showing Increased Risk of Blood Clots

The FDA will hold hearings next month to consider the risks of blood clots associated with Yaz, Yasmin, Ocella, and Beyaz. Although approximately six studies now show an increased risk, the FDA has not yet determined whether to officially update the warnings on these pills. The agency is widely expected to make a decision at or shortly ...

continue reading...

FDA Announces Yaz/Yasmin Increase the Risk of Blood Clots by up to 75%

Large study shows “significantly higher risk” compared with “low-estrogen” pills

The FDA announced today that it has published a large retrospective study showing that women on birth control pills that contain drospirenone, an ingredient in Yaz, Yasmin, Ocella, and Beyaz, are approximately 75% more likely to have a blood clot than women on safer, established birth control pills.

Combined with the Danish study announced in the New York Times this ...

continue reading...

New York Times Publishes Article about New Yaz/Blood Clot Study

Yet Another Study Shows Increased Risk of Blood Clots for Yaz, Yasmin,Ocella, and Beyaz

The New York Times announced today that “A new study of 1.3 million Danish women over nine years adds to the evidence that some newer birth-control pills, including the best-seller Yaz, have a higher risk of causing potentially dangerous blood clots.”  That makes approximately 5 studies in recent years suggesting a higher risk of blood clots ...

continue reading...
Page 8 of 8 «...45678